Pricing Log in Create free account
Saturday 17 October 2026 Export PODD’s income statement to Excel — free account

Insulet Corporation

PODD Healthcare Medical Devices

Insulet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 30.7% from fiscal 2024. In the quarter to June 2026, revenue grew 23.5%, EPS grew 328.1%, free cash flow fell 70.5% and total debt fell 32.2%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

141.10 2.33 +1.68%
Market cap
$9.6B
P/E
26.4×
Fwd P/E
24.7×
Dividend yield
—
F-score
6/9
Altman Z
9.09
Beneish M
−2.59
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Insulet Corporation (PODD) Gross margin

Alert me on Gross margin

Insulet Corporation's gross margin over the twelve months to 30 June 2026 was 71.1%, down 0.6 percentage points from fiscal 2025 (71.6%). Over the past ten years it has ranged from 50.5% (fiscal 2015) to 71.6% (fiscal 2025) — the current reading is the highest in ten years. That is above the Medical Devices industry median of 56.0% and above the Healthcare sector median of 53.5%.

Gross margin, annual

Embed this chart

Annual newest first

Period Gross margin Change (points)
FY2025 71.6% 1.84
FY2024 69.8% 1.44
FY2023 68.4% 6.63
FY2022 61.7% (6.73)
FY2021 68.5% 4.06
FY2020 64.4% (0.67)
FY2019 65.1% (0.60)
FY2018 65.7% 5.89
FY2017 59.8% 2.25
FY2016 57.5% 7.02

Quarterly newest first

Period Gross margin Change (points)
Jun 2026 70.2% 0.73
Mar 2026 69.5% (3.09)
Dec 2025 72.5% 0.32
Sep 2025 72.2% 2.55
42 more quarters

Against its own ten years

Low 50.5% High 71.6%
Ten-year median 65.1%
Current reading's percentile 95

Gross margin against peers

Company Gross margin
GKOS Glaukos Corporation compare 79.1%
PODD Insulet Corporation 71.1%
SNN Smith & Nephew SNATS, Inc. compare 70.5%
GMED Globus Medical, Inc. compare 68.6%
PEN Penumbra, Inc. compare 67.8%
HAE Haemonetics Corporation compare 59.0%
BIO.B Bio-Rad Laboratories, Inc. compare 51.9%
BIO Bio-Rad Laboratories, Inc. compare 51.9%
BRKR Bruker Corporation compare 46.4%
Medical Devices industry median 56.0%
Healthcare sector median 53.5%
Market median 46.2%

What Gross margin is

Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.

Gross Profit ÷ Revenue

The full definition of Gross margin →

More on PODD